WVXU: Concern over PFAS in our water may not be over
UC scientist discusses impact of drinking water pollutants in region and nation
The recent movie “Dark Waters” continues to drive conversations about pollutants in the nation’s drinking water. The environmental thriller is based off of the real story of Cincinnati attorney Robert Bilott and an environmental lawsuit he brought against one of the world’s largest chemical companies, DuPont. It was filmed in our region and its subject matter has raised concerns about PFOA, also known as perfluorooctanoic acid, and PFAS, also known as polyfluoroalkyl substances.
Susan Pinney, a professor in the UC Department of Environmental Health and director of the UC Center for Environmental Genetics, has studied the impact of PFOA and PFAS for much of her professional career. She joined Cincinnati Edition to discuss health concerns associated with these pollutants along with officials from the Sierra Club Gender, Equity and Environment Program and the Ohio Environmental Protection Agency.
UC’s Pinney authored a 2017 study that found that residents of the Mid-Ohio River Valley (from Cincinnati north to Huntington, West Virginia) had higher than normal levels of PFOA based on blood samples collected over a 22-year span. The exposure source was likely from drinking water contaminated by the industrial discharges upriver described in “Dark Waters.”
Related Stories
Taking a second look at surgery eligibility for patients with lung cancer who smoke
June 11, 2026
Researchers at the University of Cincinnati College of Medicine have found that patients who continue to smoke ahead of lung cancer surgery have a higher risk of pulmonary complications, but their short-term mortality rate is similar to patients who were able to stop smoking before surgery.. Their findings were published recently in the Journal of. American College of Surgeons
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.